Welcome to LookChem.com Sign In|Join Free
  • or
10-propionylphenothiazine is a novel phenothiazine derivative characterized as a yellow crystalline solid. It is known for its potential as a cholinesterase inhibitor, which makes it a promising candidate for various applications in the pharmaceutical industry.

6622-75-9

Post Buying Request

6622-75-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6622-75-9 Usage

Uses

Used in Pharmaceutical Industry:
10-propionylphenothiazine is used as a cholinesterase inhibitor for its ability to inhibit the activity of cholinesterase enzymes, which play a crucial role in the breakdown of acetylcholine, a neurotransmitter involved in various cognitive functions. By inhibiting cholinesterase, 10-propionylphenothiazine can help improve cognitive function and memory, making it a potential therapeutic agent for the treatment of conditions such as Alzheimer's disease and other cognitive disorders.
Additionally, due to its chemical properties as a yellow crystalline solid, 10-propionylphenothiazine may also find applications in other industries, such as in the development of dyes or pigments for various purposes. However, further research and development would be required to explore these potential uses.

Check Digit Verification of cas no

The CAS Registry Mumber 6622-75-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,6,2 and 2 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 6622-75:
(6*6)+(5*6)+(4*2)+(3*2)+(2*7)+(1*5)=99
99 % 10 = 9
So 6622-75-9 is a valid CAS Registry Number.
InChI:InChI=1/C15H13NOS/c1-2-15(17)16-11-7-3-5-9-13(11)18-14-10-6-4-8-12(14)16/h3-10H,2H2,1H3

6622-75-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Propionyl Phenothiazine

1.2 Other means of identification

Product number -
Other names 10-propionylphenothiazine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6622-75-9 SDS

6622-75-9Relevant academic research and scientific papers

One-Pot Tandem Access to Phenothiazine Derivatives from Acetanilide and 2-Bromothiophenol via Rhodium-Catalyzed C-H Thiolation and Copper-Catalyzed C-N Amination

Rui, Xiyan,Wang, Chao,Si, Dongjuan,Hui, Xuechao,Li, Keting,Wen, Hongmei,Li, Wei,Liu, Jian

, p. 6622 - 6632 (2021/05/29)

A one-pot and step economic reaction involving Rh(III)-catalyzed C-H thiolation and relay Cu(II)-catalyzed C-N amination of acetanilide and 2-bromothiophenol is reported here, with several valuable phenothiazine products obtained. This synthesis protocol proceeds from easily starting materials, demonstrating high atom economy, broad substrate scope, and good yield. Furthermore, the directing group can be easily eliminated, and chlorpromazine is provided in a large scale; thus this synthesis protocol could be utilized to construct phenothiazine scaffolds.

Structure-activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives

Darvesh, Sultan,McDonald, Robert S.,Penwell, Andrea,Conrad, Sarah,Darvesh, Katherine V.,Mataija, Diane,Gomez, Geraldine,Caines, Angela,Walsh, Ryan,Martin, Earl

, p. 211 - 222 (2007/10/03)

A number of phenothiazine N-alkyl amide derivatives were synthesized in order to examine the structure-activity relationships for inhibition of human acetylcholinesterase and butyrylcholinesterase. Several lines of evidence indicate that inhibition of butyrylcholinesterase (BuChE) is important in the treatment of certain dementias. Further testing of this concept requires inhibitors that are both BuChE-selective and robust. N-alkyl derivatives (2, 3, 4) of phenothiazine (1) have previously been found to inhibit only BuChE in a mechanism involving π-π interaction between the phenothiazine tricyclic ring system and aromatic residues in the active site gorge. To explore features of phenothiazines that affect the selectivity and potency of BuChE inhibition, a series of N-carbonyl derivatives (5-25) was synthesized and examined for the ability to inhibit cholinesterases. Some of the synthesized derivatives also inhibited AChE through a different mechanism involving carbonyl interaction within the active site gorge. Binding of these derivatives takes place within the gorge, since this inhibition disappears when the molecular volume of the derivative exceeds the estimated active site gorge volume of this enzyme. In contrast, BuChE, with a much larger active site gorge, exhibited inhibition that increased directly with the molecular volumes of the derivatives. This study describes two distinct mechanisms for binding phenothiazine amide derivatives to BuChE and AChE. Molecular volume was found to be an important parameter for BuChE-specific inhibition.

Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs

Chan, Cecil,Yin, Hong,Garforth, Jacqui,McKie, James H.,Jaouhari, Rabih,Speers, Peter,Douglas, Kenneth T.,Rock, Peter J.,Yardley, Vanessa,Croft, Simon L.,Fairlamb, Alan H.

, p. 148 - 156 (2007/10/03)

Given the role of trypanothione in the redox defenses of pathogenic trypanosomal and leishmanial parasites, in contrast to glutathione for their mammalian hosts, selective inhibitors of trypanothione reductase are potential drug leads against trypanosomiasis and leishmaniasis. In the present study, the rational drug design approach was used to discover tricyclic neuroleptic molecular frameworks as lead structures for the development of inhibitors, selective for trypanothione reductase over host glutathione reductase. From a homology-modeled structure for trypanothione reductase, replaced in the later stages of the study by the X-ray coordinates for the enzyme from Crithidia fasciculata, a series of inhibitors based on phenothiazine was designed. These were shown to be reversible inhibitors of trypanothione reductase from Trypanosoma cruzi, linearly competitive with trypanothione as substrate and noncompetitive with NADPH, consistent with ping-pong bi bi kinetics. Analogues, synthesized to define structure-activity relationships for the active site, included N-acylpromazines, 2-substituted phenothiazines, and trisubstituted promazines. Analysis of K(i) and I50 data, on the basis of calculated log P and molar refractivity values, provided evidence of a specially favored fit of small 2-substituents (especially 2-chloro and 2-trifluoromethyl), with a remote hydrophobic patch on the enzyme accessible for larger, hydrophobic 2-substituents. There was also evidence of an additional hydrophobic enzymic region available to suitable N-substituents of the promazine nucleus. K(i) data also indicated that the phenothiazine nucleus can adopt more than one inhibitory orientation in its binding site. Selected compounds were tested for in vitro activity against Trypanosoma brucei, T. cruzi, and Leishmania donovani, with selective activities in the micromolar range being determined for a number of them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 6622-75-9